Alert: Positive Investment/Fundamental Signals (11/15/22)-Mesa Laboratories Inc (NASDAQ: MLAB)


Extremely important positive changes in investment behavior have recently occurred for Mesa Laboratories Inc (NASDAQ: MLAB): the stock rose on very heavy volume, and its shorter term price trend turned up.

Mesa Laboratories Inc (NASDAQ: MLAB). Notable positive changes in fundamentals have recently occurred. Positive developments: significant quarterly sales acceleration occurred, the consensus estimate for March, 2022 increased significantly, and significant quarterly earnings acceleration occurred. Negative development: the consensus estimate for March, 2023 decreased significantly.

In light of these very positive signals we are reviewing our current Overall Rating of F. We would view the shares with optimism pending completion of this review in the next several days.


Current PriceTarget Research Rating

With future capital returns forecasted to be in line with the cost of capital, MLAB is expected to continue to be Value Creation neutral.

Mesa Laboratories has a current Value Trend Rating of F (Lowest Rating). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. Mesa Laboratories has a poor Power Rating of 20 and a poor Appreciation Score of 19, resulting in the Lowest Value Trend Rating.

Recent Price Action

Mesa Laboratories Inc (NASDAQ: MLAB) stock enjoyed a large increase of 2.1% on 11/15/22. The stock closed at $188.84. Moreover, trading volume in this advance was exceptionally high at 216% of normal. Relative to the market the stock has been weak over the last nine months but has risen 17.9% during the last week.

About John Lafferty 122561 Articles
During his career, John has developed valuation and stock rating methodologies, managed institutional portfolios and mutual funds, and provided equity research to institutional investors on thousands of companies. He has been Director of Research at PTR since its inception in 2004.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.